# OnCo record laryngeal-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/laryngeal-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "laryngeal-cancer" ;
  schema:name "Laryngeal and hypopharyngeal cancer"@en ;
  schema:alternateName "Larynx cancer"@en, "Voice box cancer"@en, "Glottic cancer"@en, "Supraglottic cancer"@en, "Hypopharynx cancer"@en ;
  schema:description "Cancer of the voice box, a head and neck cancer, announces itself with hoarseness and is highly curable when caught early, by laser surgery or radiotherapy that preserve the voice. Advanced disease is treated with chemoradiation to keep the larynx where possible, with total laryngectomy for the most extensive tumours or when other treatment fails."@en ;
  schema:url <https://onco.cc/cancers/laryngeal-cancer/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Laryngeal_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Laryngeal_cancer> ;
  onco:tag "subtype-page" ;
  onco:related <https://onco.cc/cancers/hpv-negative-head-and-neck-cancer/>, <https://onco.cc/cancers/oral-cavity-cancer/>, <https://onco.cc/cancers/oropharyngeal-cancer/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-keynote-048-lancet-2019/>, <https://onco.cc/key-papers/paper-rtog-91-11-forastiere-nejm-2003/>, <https://onco.cc/key-papers/paper-rtog-91-11-long-term-forastiere-jco-2013/>, <https://onco.cc/key-papers/paper-va-larynx-induction-chemotherapy-nejm-1991/> ;
  onco:pipeline <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/technologies/adaptive-radiotherapy/> ;
  onco:standardOfCare <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/trials/rtog-91-11/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/trials/keynote-048/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/technologies/smoking-cessation-after-diagnosis/>, <https://onco.cc/technologies/alcohol-reduction-labelling/> .